This bilingual comparison describes Biguanides and GLP-1 receptor agonists as therapeutic classes. It does not name specific brands — that conversation happens with your prescriber in a structured visit.
Biguanides: the basics
First-line oral therapy for type 2 diabetes. Improves insulin sensitivity and reduces hepatic glucose production.
- How it works: Reduces glucose released by the liver and helps muscle and fat tissue use insulin more effectively.
- Common effects: Common: GI side effects during titration. Kidney function monitored on routine labs.
- Conditions treated: diabetes-doral
GLP-1 receptor agonists: the basics
A therapeutic class with FDA-approved indications for type 2 diabetes management and chronic weight management when criteria are met. Used as part of a medically supervised program that includes lifestyle, nutrition, and laboratory monitoring.
- How it works: Acts on the GLP-1 hormonal pathway to slow gastric emptying, improve insulin response, and reduce appetite signaling. Used per FDA-approved indications.
- Common effects: Common: nausea, GI changes, especially during dose titration. Less common: gallbladder events, pancreatitis. Discuss family history and contraindications with your prescriber.
- Conditions treated: diabetes-doral, obesity-doral
When Biguanides is typically chosen
- First-line for some of the conditions listed above
- When the tolerability profile fits your history
- When clinical evidence for your specific diagnosis supports it
When GLP-1 receptor agonists is typically chosen
- When Biguanides are not tolerated or not effective alone
- When a different side-effect profile fits better
- When a specific clinical indication favors this class
How to decide with your prescriber
The choice is not academic — it depends on your personal history, comorbidities, other medications, pregnancy plans if applicable, and prior response to this or similar classes. A structured visit at Viva Medical Center reviews all these factors before any prescription.
- Full clinical history, including prior trials
- Review of current medications and possible interactions
- Discussion of side-effect profile vs your tolerance
- Follow-up plan — visit and lab cadence
- What to change if the first choice does not work
Frequently Asked Questions
Which is better: Biguanides or GLP-1 receptor agonists?
Neither class is universally "better." Both are chosen based on diagnosis, personal history, and tolerability. A prescriber reviews these factors in a structured visit.
Can I switch between classes if the first does not work?
Yes, this is common. Your prescriber plans the switch carefully to avoid interactions and preserve progress.
How long does each class take to work?
Onset depends on the class and the condition — weeks for mental health classes, days to weeks for metabolic classes. Your follow-up plan is calibrated to that.
Are these classes covered by insurance?
Most classes listed have options covered by major Miami-Dade carriers. We verify your specific plan at intake.
Do I need labs before starting?
Depends on the class. Some require baseline labs (liver, kidney, metabolic) and ongoing monitoring. This is discussed at the first visit.
Is this consultation available in Spanish?
Yes. The entire consultation — intake, evaluation, prescription, follow-up — is available bilingual at Viva Medical Center.